Information about new psychotropic drugs, a summary of advances in knowledge about identifiable risk factors for adverse effects, and updated recommendations on viable antidote management strategies including novel pharmacotherapies for tardive dyskinesia and newer agents for weight loss, are among the features of this new, second edition of Managing the Side Effects of Psychotropic Medications.